PATENT CLAIM ANALYSIS

Application Number: 16017805
Application Type: Utility
Filing Date: 2018-06
Publication Date: 2018-10
Patent Classification: ["514", "530000"]

Abstract:
The invention provides novel pharmaceutical compositions for the treatment of increased intraocular pressure based on semifluorinated alkanes which are useful as carriers for a broad range of active ingredients. Preferred active ingredients include poorly water-soluble prostaglandin analogues. The compositions can be administered topically into the eye. The invention further provides kits comprising such compositions.

Claim (Index 21):
The method of  claim 16 , wherein the semifluorinated alkane is F4H5, being formulated as a solution.

Metadata:
- Claim Count in Document: 29.0
- Percentile: 94.0
- Lexical Diversity: 1.31818
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: True
- Related Applications: ['13581396', '14973461', '13884785', '13513886', '13824048']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7868991749184435
- 35 USC 102 Novelty (BERT): 0.5794502231307069
- Combined Prediction Score: 0.7661542797396699
- Mean Citation Score: 333.883432
- Max Citation Score: 485.7479
- Similarity Product: 344.71915225152367

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test